All changes for the tissue liver (60)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA1510
ribosomal protein L37
Molecular
liver
Mouse
Rpl37
4.0% Increase Gene Expression Level
DAA1557
ribosome binding protein 1
Molecular
liver
Mouse
Rrbp1
6.0% Increase Gene Expression Level
DAA1554
RIKEN cDNA 1110002B05 gene
Molecular
liver
Mouse
1110002B05Rik
5.0% Increase Gene Expression Level
DAA1514
squalene epoxidase
Molecular
liver
Mouse
Sqle
26.0% Increase Gene Expression Level
DAA1547
ST3 beta-galactoside alpha-2,3-sialyltransferase 3
Molecular
liver
Mouse
St3gal3
25.0% Increase Gene Expression Level
DAA849
telomere shortening
Molecular
liver
Human
—
—
DAA1529
trefoil factor 3, intestinal
Molecular
liver
Mouse
Tff3
97.0% Increase Gene Expression Level
DAA1515
tripartite motif-containing 43A
Molecular
liver
Mouse
Trim43a
5.0% Decrease Gene Expression Level
DAA1061
Variability in clearance of hepatically metabolized drugs
Physiological
liver
Human
—
—
DAA588
Viral hepatitis
Pathological
liver
Human
—
SeriesMorbidity
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA1510 | ribosomal protein L37 | Molecular | liver | Mouse | Rpl37 | 4.0% Increase Gene Expression Level | |
DAA1557 | ribosome binding protein 1 | Molecular | liver | Mouse | Rrbp1 | 6.0% Increase Gene Expression Level | |
DAA1554 | RIKEN cDNA 1110002B05 gene | Molecular | liver | Mouse | 1110002B05Rik | 5.0% Increase Gene Expression Level | |
DAA1514 | squalene epoxidase | Molecular | liver | Mouse | Sqle | 26.0% Increase Gene Expression Level | |
DAA1547 | ST3 beta-galactoside alpha-2,3-sialyltransferase 3 | Molecular | liver | Mouse | St3gal3 | 25.0% Increase Gene Expression Level | |
DAA849 | telomere shortening | Molecular | liver | Human | — | — | |
DAA1529 | trefoil factor 3, intestinal | Molecular | liver | Mouse | Tff3 | 97.0% Increase Gene Expression Level | |
DAA1515 | tripartite motif-containing 43A | Molecular | liver | Mouse | Trim43a | 5.0% Decrease Gene Expression Level | |
DAA1061 | Variability in clearance of hepatically metabolized drugs | Physiological | liver | Human | — | — | |
DAA588 | Viral hepatitis | Pathological | liver | Human | — | SeriesMorbidity |